AMAREL Side Effects

7014587-6 | Dehydration, Diarrhoea, Hyperkalaemia, Hypoglycaemia, Hyponatraemia, Malaise, Renal Failure Acute, Vomiting
on Sep 21, 2010 Female patient from FRANCE , 67 years of age, was diagnosed with type 2 diabetes mellitus, erysipelas and was treated with Amarel (View Usage). Patient experienced the following unwanted or unexpected effects: dehydration, diarrhoea, hyperkalaemia, hypoglycaemia, hyponatraemia, malaise, renal failure acute, vomiting. Amarel dosage: . During the same period patient was treated with AMOXICILLIN AND CLAVULANATE POTASSIUM (View Amoxicillin And Clavulanate Potassium Review and Amoxicillin And Clavulanate Potassium Label ), BRISTOPEN (View Bristopen Review and Bristopen Label ), OLMESARTAN MEDOXOMIL (View Olmesartan Medoxomil Review and Olmesartan Medoxomil Label ), METFORMIN (View Metformin Review and Metformin Label ), INSULIN DETEMIR (Dose:100 International Unit(s)/millilitre) (View Insulin Detemir Review and Insulin Detemir Label ), VASTEN (View Vasten Review and Vasten Label ), FLUDROCORTISONE (View Fludrocortisone Review and Fludrocortisone Label ), HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ). Patient was hospitalized.

6920933-1 | Acute Respiratory Failure, Hypoglycaemia
Patient was taking Amarel (View Usage). Patient had the following side effects: acute respiratory failure, hypoglycaemia on Aug 10, 2010 from FRANCE Additional patient health information: Female patient , 66 years of age, . Amarel dosage: . During the same period patient was treated with CACIT VITAMINE D3 (View Cacit Vitamine D3 Review and Cacit Vitamine D3 Label ), PIOGLITAZONE (View Pioglitazone Review and Pioglitazone Label ), ALDACTONE (View Aldactone Review and Aldactone Label ). Patient was hospitalized.

6920767-8 | Ascites, Cholestasis, Cytolytic Hepatitis, Hepatic Failure, Jaundice
Adverse event was reported on Aug 05, 2010 by a Female patient taking Amarel (View Usage) (Dosage: ) . Location: FRANCE , 76 years of age, After Amarel was administered, patient had the following side effects: ascites, cholestasis, cytolytic hepatitis, hepatic failure, jaundice (What is jaundice?). During the same period patient was treated with KARDEGIC (View Kardegic Review and Kardegic Label ), FENOFIBRATE (View Fenofibrate Review and Fenofibrate Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), NIDREL (View Nidrel Review and Nidrel Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), TENORMIN (View Tenormin Review and Tenormin Label ). Patient was hospitalized.

6781523-7 | Bradycardia, Cardiac Failure, Dyspnoea, Oedema Peripheral, Oliguria
on Jun 14, 2010 Female patient from FRANCE , 90 years of age, was treated with Amarel (View Usage). Patient experienced the following unwanted or unexpected effects: bradycardia, cardiac failure, dyspnoea, oedema peripheral, oliguria. Amarel dosage: . During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), PIOGLITAZONE (View Pioglitazone Review and Pioglitazone Label ), CARDENSIEL (View Cardensiel Review and Cardensiel Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), PERINDOPRIL (View Perindopril Review and Perindopril Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), DIFFU K (View Diffu K Review and Diffu K Label ), PREVISCAN (View Previscan Review and Previscan Label ). Patient was hospitalized.


6573665-6 | Cheilitis, Cholestasis, Mucosal Inflammation, Pyrexia, Rash Maculo-papular, Renal Failure Chronic
on Feb 04, 2010 Female patient from FRANCE , 78 years of age, was diagnosed with type 2 diabetes mellitus, gout (What is gout?), arthralgia and was treated with Amarel (View Usage). Patient had the following side effects: cheilitis, cholestasis, mucosal inflammation, pyrexia, rash maculo-papular, renal failure chronic. Amarel dosage: . During the same period patient was treated with ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), VOLTAREN (View Voltaren Review and Voltaren Label ), COLCHICINE (View Colchicine Review and Colchicine Label ), GLUCOPHAGE (View Glucophage Review and Glucophage Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), BUFLOMEDIL (View Buflomedil Review and Buflomedil Label ), LASILIX (View Lasilix Review and Lasilix Label ), CELECTOL (View Celectol Review and Celectol Label ). Patient was hospitalized.

6571451-4 | Bradycardia, Hyperkalaemia, Lactic Acidosis, Renal Failure Acute
Patient was taking Amarel (View Usage). After Amarel was administered, patient had the following side effects: bradycardia, hyperkalaemia, lactic acidosis, renal failure acute on Feb 03, 2010 from FRANCE Additional patient health information: Male patient , 63 years of age, . Amarel dosage: . During the same period patient was treated with LANZOR (View Lanzor Review and Lanzor Label ), ALDALIX (View Aldalix Review and Aldalix Label ), NEXEN (View Nexen Review and Nexen Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), CRESTOR (View Crestor Review and Crestor Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), LERCAN (View Lercan Review and Lercan Label ), PLAVIX (View Plavix Review and Plavix Label ). Patient was hospitalized.

6550838-X | Bradycardia, Hyperkalaemia, Lactic Acidosis, Renal Failure Acute
Adverse event was reported on Jan 22, 2010 by a Male patient taking Amarel (View Usage) (Dosage: ) . Location: FRANCE , 63 years of age, Patient experienced the following unwanted or unexpected effects: bradycardia, hyperkalaemia, lactic acidosis, renal failure acute. During the same period patient was treated with LANZOR (View Lanzor Review and Lanzor Label ), ALDALIX (View Aldalix Review and Aldalix Label ), NEXEN (View Nexen Review and Nexen Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), CRESTOR (View Crestor Review and Crestor Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), LERCAN (View Lercan Review and Lercan Label ), PLAVIX (View Plavix Review and Plavix Label ). Patient was hospitalized.

6509676-6 | Extremity Necrosis, Ischaemia
on Dec 16, 2009 Male patient from FRANCE , 69 years of age, was diagnosed with type 2 diabetes mellitus, mixed hepatocellular cholangiocarcinoma and was treated with Amarel (View Usage). Patient had the following side effects: extremity necrosis, ischaemia. Amarel dosage: . During the same period patient was treated with GEMCITABINE (Dose:38 Milligram(s)/millilitre) (View Gemcitabine Review and Gemcitabine Label ), FENOFIBRATE (View Fenofibrate Review and Fenofibrate Label ), FOZITEC (View Fozitec Review and Fozitec Label ).

6492343-5 | Hypoglycaemic Coma
on Dec 07, 2009 Female patient from FRANCE , 88 years of age, was treated with Amarel (View Usage). After Amarel was administered, patient had the following side effects: hypoglycaemic coma. Amarel dosage: . During the same period patient was treated with KETEK (View Ketek Review and Ketek Label ), FLUIMUCIL (View Fluimucil Review and Fluimucil Label ), COKENZEN (View Cokenzen Review and Cokenzen Label ). Patient was hospitalized.

6409217-8 | Pancreatitis Acute, Renal Failure Acute
Patient was taking Amarel (View Usage). Patient experienced the following unwanted or unexpected effects: pancreatitis acute, renal failure acute on Oct 14, 2009 from Additional patient health information: Male patient , 66 years of age, weighting 200.6 lb, was diagnosed with vitamin d deficiency and. Amarel dosage: . During the same period patient was treated with ORAL ANTIDIABETICS (View Oral Antidiabetics Review and Oral Antidiabetics Label ), COAPROVEL (View Coaprovel Review and Coaprovel Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), ASPEGIC 1000 (View Aspegic 1000 Review and Aspegic 1000 Label ), AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), HYPERIUM /00939801/ (View Hyperium /00939801/ Review and Hyperium /00939801/ Label ), UVEDOSE (View Uvedose Review and Uvedose Label ), CAPTOPRIL AND HYDROCHLOROTHIAZIDE (View Captopril And Hydrochlorothiazide Review and Captopril And Hydrochlorothiazide Label ). Patient was hospitalized.

5766077-6 | Hypoglycaemia
Adverse event was reported on May 30, 2008 by a Male patient taking Amarel (View Usage) (Dosage: ) . Location: , 84 years of age, Patient had the following side effects: hypoglycaemia. During the same period patient was treated with DIANTALVIC (View Diantalvic Review and Diantalvic Label ), IRBESARTAN (View Irbesartan Review and Irbesartan Label ), FUCIDINE CAP (View Fucidine Cap Review and Fucidine Cap Label ), LEXOMIL (View Lexomil Review and Lexomil Label ), LOXEN (View Loxen Review and Loxen Label ), CELIPROLOL (View Celiprolol Review and Celiprolol Label ), FENOFIBRATE (View Fenofibrate Review and Fenofibrate Label ). Patient was hospitalized.

5752105-0 | Atrioventricular Block Complete, Bradycardia, Confusional State, Hyperkalaemia, Hypotension, Metabolic Acidosis, Renal Failure
on May 26, 2008 Male patient from , 72 years of age, was treated with Amarel (View Usage). After Amarel was administered, patient had the following side effects: atrioventricular block complete, bradycardia, confusional state, hyperkalaemia, hypotension, metabolic acidosis, renal failure. Amarel dosage: . During the same period patient was treated with KARDEGIC /00002703/ (View Kardegic /00002703/ Review and Kardegic /00002703/ Label ), XATRAL /00975301/ (View Xatral /00975301/ Review and Xatral /00975301/ Label ), COAPROVEL (View Coaprovel Review and Coaprovel Label ), CARDENSIEL (View Cardensiel Review and Cardensiel Label ), METFORMINE (View Metformine Review and Metformine Label ), CRESTOR (View Crestor Review and Crestor Label ), NEXIUM (View Nexium Review and Nexium Label ), DAFALGAN /00020001/ (View Dafalgan /00020001/ Review and Dafalgan /00020001/ Label ). Patient was hospitalized.

4917814-1 | Hypoglycaemic Coma
on Feb 15, 2006 Female patient from , 75 years of age, was diagnosed with diabetes mellitus, depression (What is depression?) and was treated with Amarel (View Usage). Patient experienced the following unwanted or unexpected effects: hypoglycaemic coma. Amarel dosage: Dose Unit: Units. During the same period patient was treated with DEROXAT (View Deroxat Review and Deroxat Label ), GLUCOR (View Glucor Review and Glucor Label ).

4914000-6 | Confusional State, Hypoglycaemia, Hyponatraemia, International Normalised Ratio Increased, Somnolence
Patient was taking Amarel (View Usage). Patient had the following side effects: confusional state, hypoglycaemia, hyponatraemia, international normalised ratio increased, somnolence on Feb 09, 2006 from Additional patient health information: Female patient , 71 years of age, was diagnosed with diabetes mellitus non-insulin-dependent, vulvovaginal mycotic infection and. Amarel dosage: . During the same period patient was treated with TRIFLUCAN (View Triflucan Review and Triflucan Label ), PREVISCAN (View Previscan Review and Previscan Label ), TARDYFERON (View Tardyferon Review and Tardyferon Label ). Patient was hospitalized.

4891375-8 | Anaemia, Circulatory Collapse, Colonic Haematoma, Cyst Rupture, Gastrointestinal Haemorrhage, International Normalised Ratio Increased, Malaise, Pancreatitis Haemorrhagic
Adverse event was reported on Aug 26, 2005 by a Male patient taking Amarel (View Usage) (Dosage: ) was diagnosed with diabetes mellitus non-insulin-dependent, intracardiac thrombus and. Location: , 51 years of age, After Amarel was administered, patient had the following side effects: anaemia, circulatory collapse, colonic haematoma, cyst rupture, gastrointestinal haemorrhage, international normalised ratio increased, malaise, pancreatitis haemorrhagic. During the same period patient was treated with PREVISCAN 20 MG (View Previscan 20 Mg Review and Previscan 20 Mg Label ), DIAMICRON (View Diamicron Review and Diamicron Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), CREON (View Creon Review and Creon Label ), MOPRAL (View Mopral Review and Mopral Label ).

4891372-2 | Hypoglycaemia, Loss Of Consciousness
on Jan 16, 2006 Female patient from , 86 years of age, weighting 119.0 lb, was diagnosed with diabetes mellitus, arrhythmia (What is arrhythmia?), cardiac failure, essential hypertension, anxiety (What is anxiety?) and was treated with Amarel (View Usage). Patient experienced the following unwanted or unexpected effects: hypoglycaemia, loss of consciousness. Amarel dosage: . During the same period patient was treated with CIPRALAN (View Cipralan Review and Cipralan Label ), LASILIX RETARD (View Lasilix Retard Review and Lasilix Retard Label ), TAREG (View Tareg Review and Tareg Label ), DIGOXIN (Dose Unit: Units) (View Digoxin Review and Digoxin Label ), TRANXENE (View Tranxene Review and Tranxene Label ). Patient was hospitalized.

4874544-2 | Cryptogenic Organizing Pneumonia
on Jan 02, 2006 Male patient from , 77 years of age, weighting 202.8 lb, was diagnosed with diabetes mellitus and was treated with Amarel (View Usage). Patient had the following side effects: cryptogenic organizing pneumonia. Amarel dosage: . During the same period patient was treated with KARDEGIC (View Kardegic Review and Kardegic Label ), MEDIATENSYL (View Mediatensyl Review and Mediatensyl Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), CIBADREX ^CIBA GEIGY^ (View Cibadrex ^ciba-geigy^ Review and Cibadrex ^ciba-geigy^ Label ), LANTUS (View Lantus Review and Lantus Label ). Patient was hospitalized.

4866356-0 | Anaemia, Duodenitis, Gastrointestinal Haemorrhage, Haematemesis, Mucormycosis, Normochromic Normocytic Anaemia, Oesophagitis
Patient was taking Amarel (View Usage). After Amarel was administered, patient had the following side effects: anaemia, duodenitis, gastrointestinal haemorrhage, haematemesis, mucormycosis, normochromic normocytic anaemia, oesophagitis on Nov 16, 2005 from Additional patient health information: Male patient , 69 years of age, was diagnosed with diabetes mellitus, essential hypertension, oesophagitis, acute myocardial infarction and. Amarel dosage: . During the same period patient was treated with PLAVIX (View Plavix Review and Plavix Label ), SELOKEN (View Seloken Review and Seloken Label ), NEXIUM (View Nexium Review and Nexium Label ), NICARDIPINE HCL (View Nicardipine Hcl Review and Nicardipine Hcl Label ), NITRIDERM TTS 10 MG/24 H (View Nitriderm Tts 10 Mg/24 H Review and Nitriderm Tts 10 Mg/24 H Label ). Patient was hospitalized.

4844239-X | Nephritis Interstitial
Adverse event was reported on Nov 23, 2005 by a Female patient taking Amarel (View Usage) (Dosage: ) . Location: , 70 years of age, weighting 125.7 lb, Patient experienced the following unwanted or unexpected effects: nephritis interstitial. During the same period patient was treated with NOROXIN (View Noroxin Review and Noroxin Label ), LAMISIL (View Lamisil Review and Lamisil Label ), VISIPAQUE (View Visipaque Review and Visipaque Label ). Patient was hospitalized.

4836215-8 | Anaemia, Barrett's Oesophagus, Duodenitis, Gastrointestinal Haemorrhage, Haematemesis, Normochromic Normocytic Anaemia, Oesophagitis, Systemic Mycosis
on Nov 16, 2005 Male patient from , 69 years of age, was diagnosed with diabetes mellitus, essential hypertension, oesophagitis, acute myocardial infarction and was treated with Amarel (View Usage). Patient had the following side effects: anaemia, barrett's oesophagus, duodenitis, gastrointestinal haemorrhage, haematemesis, normochromic normocytic anaemia, oesophagitis, systemic mycosis. Amarel dosage: . During the same period patient was treated with PLAVIX (View Plavix Review and Plavix Label ), SELOKEN (View Seloken Review and Seloken Label ), NEXIUM (View Nexium Review and Nexium Label ), NICARDIPINE HCL (View Nicardipine Hcl Review and Nicardipine Hcl Label ), NITRIDERM TTS 10 MG/24 H (View Nitriderm Tts 10 Mg/24 H Review and Nitriderm Tts 10 Mg/24 H Label ). Patient was hospitalized.

4831711-1 | Anuria, Haemoglobin Decreased, Hepatitis, Jaundice, Metabolic Acidosis, Renal Failure
on Sep 30, 2005 Male patient from , 75 years of age, was diagnosed with diabetes mellitus non-insulin-dependent, hyperuricaemia, essential hypertension, hypercholesterolaemia and was treated with Amarel (View Usage). After Amarel was administered, patient had the following side effects: anuria, haemoglobin decreased, hepatitis (What is hepatitis?), jaundice (What is jaundice?), metabolic acidosis, renal failure. Amarel dosage: . During the same period patient was treated with ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), MEDIATENSYL (View Mediatensyl Review and Mediatensyl Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), ACTOS (View Actos Review and Actos Label ), CRESTOR (View Crestor Review and Crestor Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), ZOFENIL (View Zofenil Review and Zofenil Label ), LEGALON (View Legalon Review and Legalon Label ).

4810531-8 | Abnormal Behaviour, Atrial Fibrillation, Confusional State, Hypoglycaemia
Patient was taking Amarel (View Usage). Patient experienced the following unwanted or unexpected effects: abnormal behaviour, atrial fibrillation (What is atrial fibrillation?), confusional state, hypoglycaemia on Oct 17, 2005 from Additional patient health information: Male patient , 79 years of age, was diagnosed with diabetes mellitus, atrial fibrillation (What is atrial fibrillation?) and. Amarel dosage: . During the same period patient was treated with GLUCOPHAGE (View Glucophage Review and Glucophage Label ), PREVISCAN 20 MG (View Previscan 20 Mg Review and Previscan 20 Mg Label ), CORDARONE (View Cordarone Review and Cordarone Label ), LOVENOX (View Lovenox Review and Lovenox Label ). Patient was hospitalized.

4803446-2 | Facial Dysmorphism, Heart Disease Congenital, Microcephaly, Oligohydramnios, Ventricular Septal Defect
Adverse event was reported on Oct 10, 2005 by a Male patient taking Amarel (View Usage) (Dosage: Dose Unit: Units) was diagnosed with diabetes mellitus and. Location: , weighting 7.94 lb, Patient had the following side effects: facial dysmorphism, heart disease congenital, microcephaly, oligohydramnios, ventricular septal defect. During the same period patient was treated with ACTRAPID (View Actrapid Review and Actrapid Label ), INSULATARD NPH HUMAN (View Insulatard Nph Human Review and Insulatard Nph Human Label ).

4791298-9 | Hepatitis, Metabolic Acidosis, Renal Failure
on Sep 30, 2005 Male patient from , 75 years of age, was diagnosed with diabetes mellitus malnutrition-related, hyperuricaemia, essential hypertension, hypercholesterolaemia and was treated with Amarel (View Usage). After Amarel was administered, patient had the following side effects: hepatitis (What is hepatitis?), metabolic acidosis, renal failure. Amarel dosage: . During the same period patient was treated with ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), MEDIATENSYL (View Mediatensyl Review and Mediatensyl Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), ACTOS (View Actos Review and Actos Label ), CRESTOR (View Crestor Review and Crestor Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), ZOFENIL (View Zofenil Review and Zofenil Label ), LEGALON (View Legalon Review and Legalon Label ).

4790245-3 | Microcephaly
on Sep 28, 2005 Female patient from , 23 years of age, weighting 238.1 lb, was diagnosed with diabetes mellitus non-insulin-dependent and was treated with Amarel (View Usage). Patient experienced the following unwanted or unexpected effects: microcephaly. Amarel dosage: . Patient was hospitalized.

4778711-8 | Acinetobacter Infection, Cholestasis, Confusional State, Duodenal Stenosis, Enterococcal Sepsis, Gastrointestinal Disorder, Klebsiella Infection, Metabolic Acidosis, Multi-organ Failure
Patient was taking Amarel (View Usage). Patient had the following side effects: acinetobacter infection, cholestasis, confusional state, duodenal stenosis, enterococcal sepsis, gastrointestinal disorder, klebsiella infection, metabolic acidosis, multi-organ failure on Jul 18, 2005 from Additional patient health information: Male patient , 80 years of age, was diagnosed with diabetes mellitus non-insulin-dependent, essential hypertension and. Amarel dosage: . During the same period patient was treated with NISIS (View Nisis Review and Nisis Label ), TENORMIN (View Tenormin Review and Tenormin Label ). Patient was hospitalized.

4761885-2 | Anaemia, Circulatory Collapse, Gastrointestinal Haemorrhage, International Normalised Ratio Increased, Malaise
Adverse event was reported on Aug 26, 2005 by a Male patient taking Amarel (View Usage) (Dosage: ) was diagnosed with diabetes mellitus non-insulin-dependent and. Location: , 51 years of age, After Amarel was administered, patient had the following side effects: anaemia, circulatory collapse, gastrointestinal haemorrhage, international normalised ratio increased, malaise. During the same period patient was treated with PREVISCAN 20 MG (View Previscan 20 Mg Review and Previscan 20 Mg Label ), DIAMICRON (View Diamicron Review and Diamicron Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), CREON (View Creon Review and Creon Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ).

4754971-4 | Anuria, Depressed Level Of Consciousness, Erysipelas, Haemodialysis, Hypoglycaemia, Multi-organ Failure, Necrotising Fasciitis, Respiratory Distress, Septic Shock
on Aug 16, 2005 Male patient from FRANCE , 62 years of age, weighting 264.6 lb, was diagnosed with diabetes mellitus insulin-dependent, myalgia, myositis (What is myositis?), gastric ulcer, hypertension and was treated with Amarel (View Usage). Patient experienced the following unwanted or unexpected effects: anuria, depressed level of consciousness, erysipelas, haemodialysis, hypoglycaemia, multi-organ failure, necrotising fasciitis, respiratory distress, septic shock. Amarel dosage: . During the same period patient was treated with DOLIPRANE (View Doliprane Review and Doliprane Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), CREON (View Creon Review and Creon Label ), TRANDATE (View Trandate Review and Trandate Label ), UPFEN (View Upfen Review and Upfen Label ).

4753633-7 | Anuria, Haemodialysis, Hypoglycaemia, Multi-organ Failure, Necrotising Fasciitis, Respiratory Distress, Septic Shock, Streptococcal Infection, Thrombocytopenia
on Aug 16, 2005 Male patient from FRANCE , 62 years of age, weighting 264.6 lb, was diagnosed with diabetes mellitus non-insulin-dependent, myalgia, myositis (What is myositis?), gastric ulcer, hypertension and was treated with Amarel (View Usage). Patient had the following side effects: anuria, haemodialysis, hypoglycaemia, multi-organ failure, necrotising fasciitis, respiratory distress, septic shock, streptococcal infection (What is streptococcal infection?), thrombocytopenia. Amarel dosage: . During the same period patient was treated with DOLIPRANE (View Doliprane Review and Doliprane Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), CREON (View Creon Review and Creon Label ), TRANDATE (View Trandate Review and Trandate Label ), UPFEN (View Upfen Review and Upfen Label ).

4752642-1 | Pancreatitis Acute, Renal Failure
Patient was taking Amarel (View Usage). After Amarel was administered, patient had the following side effects: pancreatitis acute, renal failure on Jul 18, 2005 from Additional patient health information: Male patient , 80 years of age, was diagnosed with diabetes mellitus non-insulin-dependent, essential hypertension and. Amarel dosage: . During the same period patient was treated with NISIS (View Nisis Review and Nisis Label ), TENORMIN (View Tenormin Review and Tenormin Label ). Patient was hospitalized.

4726024-2 | Pancreatitis Acute
Adverse event was reported on Jul 18, 2005 by a Male patient taking Amarel (View Usage) (Dosage: ) was diagnosed with diabetes mellitus non-insulin-dependent, essential hypertension and. Location: , 80 years of age, Patient experienced the following unwanted or unexpected effects: pancreatitis acute. During the same period patient was treated with NISIS (View Nisis Review and Nisis Label ), TENORMIN (View Tenormin Review and Tenormin Label ). Patient was hospitalized.

4586808-0 | Duodenal Ulcer
on Feb 10, 2005 Male patient from , 79 years of age, was diagnosed with diabetes mellitus non-insulin-dependent and was treated with Amarel (View Usage). Patient had the following side effects: duodenal ulcer. Amarel dosage: . During the same period patient was treated with LASILIX (View Lasilix Review and Lasilix Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), CARDENSIEL (View Cardensiel Review and Cardensiel Label ), NEXIUM (View Nexium Review and Nexium Label ), ZOCOR (View Zocor Review and Zocor Label ). Patient was hospitalized.

4574199-0 | Carotid Artery Stenosis, Diabetes Mellitus Inadequate Control, Fall, Hot Flush, Orthostatic Hypotension
on Feb 02, 2005 Male patient from , 68 years of age, was diagnosed with diabetes mellitus, essential hypertension, dysthymic disorder and was treated with Amarel (View Usage). After Amarel was administered, patient had the following side effects: carotid artery stenosis, diabetes mellitus inadequate control, fall (What is fall?), hot flush, orthostatic hypotension. Amarel dosage: . During the same period patient was treated with TRIATEC (View Triatec Review and Triatec Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), DETENSIEL (View Detensiel Review and Detensiel Label ), DEROXAT (View Deroxat Review and Deroxat Label ), TRINIPATCH (View Trinipatch Review and Trinipatch Label ), ZOCOR (View Zocor Review and Zocor Label ). Patient was hospitalized.

4571627-1 | Cerebrovascular Accident, Face Injury, Fall, Hypoglycaemia
Patient was taking Amarel (View Usage). Patient experienced the following unwanted or unexpected effects: cerebrovascular accident, face injury, fall (What is fall?), hypoglycaemia on Jan 27, 2005 from Additional patient health information: Female patient , 83 years of age, weighting 110.2 lb, was diagnosed with diabetes mellitus, hypertension, prophylaxis, arrhythmia (What is arrhythmia?) and. Amarel dosage: . During the same period patient was treated with DIAMICRON (View Diamicron Review and Diamicron Label ), COVERSYL (View Coversyl Review and Coversyl Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), CORDARONE (View Cordarone Review and Cordarone Label ), VASTAREL (View Vastarel Review and Vastarel Label ). Patient was hospitalized.

4571626-X | Anoxia, Arrhythmia, Cardiac Arrest, Cerebral Disorder, Coma, Electroencephalogram Abnormal, Nosocomial Infection, Pneumonia
Adverse event was reported on Jan 27, 2005 by a Male patient taking Amarel (View Usage) (Dosage: ) was diagnosed with diabetes mellitus non-insulin-dependent and. Location: , 74 years of age, Patient had the following side effects: anoxia, arrhythmia (What is arrhythmia?), cardiac arrest (What is cardiac arrest?), cerebral disorder, coma, electroencephalogram abnormal, nosocomial infection, pneumonia (What is pneumonia?). During the same period patient was treated with VISKEN (View Visken Review and Visken Label ), OMIX (View Omix Review and Omix Label ), VIOXX (View Vioxx Review and Vioxx Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ).

4546014-2 | Abdominal Pain, Dehydration, Diarrhoea, Hypovolaemic Shock, Metastases To Peritoneum, Neoplasm Recurrence, Platelet Count Decreased, Rectal Haemorrhage, Renal Failure Acute
on Dec 29, 2004 Female patient from , 74 years of age, was diagnosed with ovarian cancer and was treated with Amarel (View Usage). After Amarel was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), dehydration, diarrhoea, hypovolaemic shock, metastases to peritoneum, neoplasm recurrence, platelet count decreased, rectal haemorrhage, renal failure acute. Amarel dosage: . During the same period patient was treated with HYCAMTIN (View Hycamtin Review and Hycamtin Label ), DIAMICRON (View Diamicron Review and Diamicron Label ), XANAX (View Xanax Review and Xanax Label ).